Requires the Comptroller General to conduct a study and report to Congress on: (1) the impact of price controls on pharmaceuticals by foreign governments, including the impact on market access for U.S. pharmaceuticals and on pharmaceutical prices for U.S. consumers; and (2) the extent to which negotiations conducted by the U.S. Trade Representative under the Bipartisan Trade Promotion Authority Act of 2002 facilitate the elimination of such price controls.
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Trade.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line